Allison Dorval's Net Worth
$9.13 Million
Who is Allison Dorval?
Allison Dorval has an estimated net worth of $9.13 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Voyager Therapeutics, Inc., Verve Therapeutics, Inc., Aerovate Therapeutics, Inc., and PUMA BIOTECHNOLOGY, INC..
SEC CIK
Allison Dorval's CIK is 0001625110
Past Insider Trading and Trends
2021 was Allison Dorval's most active year for acquiring shares with 7 total transactions. Allison Dorval's most active month to acquire stocks was the month of January. 2015 was Allison Dorval's most active year for disposing of shares, totalling 3 transactions. Allison Dorval's most active month to dispose stocks was the month of October. 2023 saw Allison Dorval paying a total of $0.00 for 224,175 shares, this is the most they've acquired in one year. In 2020 Allison Dorval cashed out on 3,128 shares for a total of $41,790.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSULET CORP (PODD) Snapshot price: $214.75
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.13% | -814.00 |
$31.85 | -$25,925.90 | 37.41K |
Apr 1
| |||
Form 4
| +32.62% | 9.4K |
$31.37 | -$26,695.87 | 38.23K |
Mar 2 - Mar 3
| |||
Form 4
| -3.65% | -1.09K |
$31.73 | -$34,617.43 | 28.83K |
Mar 1
| |||
Form 4
| +33.91% | 7.58K |
—
|
—
| 29.92K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.55% | 30K |
—
|
—
| 109.89K |
Mar 19
| |||
Form 4
| +74.08% | 34K |
—
|
—
| 79.89K |
Feb 16
| |||
Form 4
| -6.49% | -3.19K |
$7.55 | -$24,054.30 | 45.89K |
Scheduled
|
Feb 11
| ||
Form 4
| -5.66% | -2.94K |
$8.62 | -$25,360.04 | 49.08K |
Scheduled
|
Jan 12
| ||
Form 4
| +112.14% | 27.5K |
—
|
—
| 52.02K |
Feb 10
| |||
Form 4
| -11.31% | -3.13K |
$13.36 | -$41,790.08 | 24.52K |
Scheduled
|
Jan 21
| ||
Form 4
| +2,260.40% | 25K |
—
|
—
| 26.11K |
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +48.23% | 1.32K |
$11.45 | -$6,343.30 | 4.06K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +152.72% | 1.32K |
$22.10 | -$12,243.40 | 2.19K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $2.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +81.82% | 27K |
—
|
—
| 60K |
Jun 18
| |||
Form 4
| -25.00% | -11.00K |
$3.37 | -$37,096.40 | 33K |
Scheduled
|
Jun 13
| ||
Form 4
| +62.96% | 17K |
$3.45 | -$34,500.00 | 44K |
Jun 13
| |||
Form 4
|
∞
| 27K |
—
|
—
| 27K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |